4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0000899243-21-026556
SVP, General Counsel bought 1,088 shares at $9.01 ($9,803)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Oltmans Curtis Gale SVP, General Counsel | 2021-06-28 | Purchase | +1,088 | $9.01 | $9,803 | 1,088 | D: show line 1 in the form |
| Open-market purchases · 1,088 sh · avg $9.01 · $9,803 | |||||||
Loading xslF345X03/doc4.xml…